secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evofem Biosciences, Inc. (EVFM)
CIK:        0001618835
Form:       8-K
Filed at:   2024-09-25T23:59:59+00:00
Accession:  0001493152-24-038113
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evofem Biosciences sells $260k Series F-1 Preferred Stock to Aditxt in private placement
--------------------------------------------------------------------------------

- Sold 260 shares of Series F-1 Preferred Stock to Aditxt for $260,000 on September 20, 2024.
- Preferred shares are convertible into common stock; registration rights agreement requires filing within 300 days.
- Private placement is part of consideration under the Amended Merger Agreement with Aditxt (previously disclosed).
- Securities issued in reliance on Section 4(a)(2) exemption from registration under the Securities Act.
- Company must use best efforts to have registration statement declared effective within 90 days of filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1618835/000149315224038113/0001493152-24-038113-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1618835/000149315224038113/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-038113

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer